TURKISH JOURNAL OF HEMATOLOGY, vol.29, no.2, pp.120-125, 2012 (SCI-Expanded)
Objective: Multidrug resistance is a cause of treatment failure in patients with malignant lymphoma; however, the frequency and clinical relevance of multidrug resistance protein expression are unclear. The present study aimed to investigate expression of the most common multidrug resistance proteins in a group of lymphoma patients.